These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 31278209

  • 1. A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcome.
    Beksac M, Seval GC, Kanellias N, Coriu D, Rosiñol L, Ozet G, Goranova-Marinova V, Unal A, Bila J, Ozsan H, Ivanaj A, Balić LI, Kastritis E, Bladé J, Dimopoulos MA.
    Haematologica; 2020 Jan; 105(1):201-208. PubMed ID: 31278209
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma.
    Chu TH, Jung SH, Kim K, Lee JH, Mun YC, Bang SM, Yoon DH, Lee HS, Min CK, Lee JJ.
    Ann Hematol; 2022 Jun; 101(6):1217-1226. PubMed ID: 35445844
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Late Relapse of Multiple Myeloma with Testicular Plasmacytoma after Autologous Hematopoietic Stem Cell Transplantation: A Case Report and Review of the Literature.
    Wei ZL, Pan CM, Jiang YZ, Yan-Dai, Huanguang LQ, Huang DP.
    Ann Clin Lab Sci; 2018 Jan; 48(1):120-125. PubMed ID: 29531008
    [Abstract] [Full Text] [Related]

  • 6. [Effects of extramedullary disease on patients with newly diagnosed multiple myeloma].
    Tao Y, Jin SW, Wang Y, Tang SJ, Liu YF, Xu J, Pan MM, Zhang WP, Mi JQ.
    Zhonghua Xue Ye Xue Za Zhi; 2023 Jan 14; 44(1):48-54. PubMed ID: 36987723
    [Abstract] [Full Text] [Related]

  • 7. The role of positron emission tomography with 18F-fluorodeoxyglucose integrated with computed tomography in the evaluation of patients with multiple myeloma undergoing allogeneic stem cell transplantation.
    Patriarca F, Carobolante F, Zamagni E, Montefusco V, Bruno B, Englaro E, Nanni C, Geatti O, Isola M, Sperotto A, Buttignol S, Stocchi R, Corradini P, Cavo M, Fanin R.
    Biol Blood Marrow Transplant; 2015 Jun 14; 21(6):1068-73. PubMed ID: 25754658
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.
    Cavo M, Gay F, Beksac M, Pantani L, Petrucci MT, Dimopoulos MA, Dozza L, van der Holt B, Zweegman S, Oliva S, van der Velden VHJ, Zamagni E, Palumbo GA, Patriarca F, Montefusco V, Galli M, Maisnar V, Gamberi B, Hansson M, Belotti A, Pour L, Ypma P, Grasso M, Croockewit A, Ballanti S, Offidani M, Vincelli ID, Zambello R, Liberati AM, Andersen NF, Broijl A, Troia R, Pascarella A, Benevolo G, Levin MD, Bos G, Ludwig H, Aquino S, Morelli AM, Wu KL, Boersma R, Hajek R, Durian M, von dem Borne PA, Caravita di Toritto T, Zander T, Driessen C, Specchia G, Waage A, Gimsing P, Mellqvist UH, van Marwijk Kooy M, Minnema M, Mandigers C, Cafro AM, Palmas A, Carvalho S, Spencer A, Boccadoro M, Sonneveld P.
    Lancet Haematol; 2020 Jun 14; 7(6):e456-e468. PubMed ID: 32359506
    [Abstract] [Full Text] [Related]

  • 11. Comparison of clinical features of multiple myeloma with paraosseous and extraosseous plasmacytoma in the era of novel drugs: a systemic review and meta-analysis.
    Zhou D, Zhou X, Xu P, Chen B.
    Expert Rev Hematol; 2022 Apr 14; 15(4):369-374. PubMed ID: 35387532
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Predictors and Impact of Timing of Disease Progression Following Primary Therapy in Multiple Myeloma.
    Goldman-Mazur S, Visram A, Rajkumar SV, Kapoor P, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Hayman SR, Dingli D, Kourelis T, Gonsalves W, Warsame R, Muchtar E, Leung N, Kyle RA, Kumar SK.
    Clin Lymphoma Myeloma Leuk; 2024 Mar 14; 24(3):e104-e111.e1. PubMed ID: 38135634
    [Abstract] [Full Text] [Related]

  • 14. Paraskeletal and extramedullary plasmacytomas in multiple myeloma at diagnosis and at first relapse: 50-years of experience from an academic institution.
    Jiménez-Segura R, Rosiñol L, Cibeira MT, Fernández de Larrea C, Tovar N, Rodríguez-Lobato LG, Bladé E, Moreno DF, Oliver-Caldés A, Bladé J.
    Blood Cancer J; 2022 Sep 16; 12(9):135. PubMed ID: 36114167
    [Abstract] [Full Text] [Related]

  • 15. Recurrent extramedullary plasmacytoma in asymptomatic multiple myeloma: a case report.
    Schols SE, Tick LL.
    J Med Case Rep; 2015 Feb 19; 9():37. PubMed ID: 25880694
    [Abstract] [Full Text] [Related]

  • 16. Primary extramedullary plasmacytoma and multiple myeloma: phenotypic differences revealed by immunohistochemical analysis.
    Kremer M, Ott G, Nathrath M, Specht K, Stecker K, Alexiou C, Quintanilla-Martinez L, Fend F.
    J Pathol; 2005 Jan 19; 205(1):92-101. PubMed ID: 15586381
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.